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Abstract
Introduction: Only limited data are available on consent and satisfaction of patients receiving specialized
neurocritical care. In this study we (i) analyzed the extent of retrospective consent to neurocritical care–given by
patients or their relatives–depending on functional outcome one year after hospital stay, and (ii) identified
predisposing factors for retrospective agreement to neurocritical care.
Methods: We investigated 704 consecutive patients admitted to a nonsurgical neurocritical care unit over a period
of 2 years (2006 through 2007). Demographic and clinical parameters were analyzed, and the patients were
grouped according to their diagnosis. Functional outcome, retrospective consent to neurocritical care, and
satisfaction with hospital stay was obtained by mailed standardized questionnaires. Logistic regression analyses
were calculated to determine independent predictors for consent.
Results: High consent and satisfaction after neurointensive care (91% and 90%, respectively) was observed by
those patients who reached an independent life one year after neurointensive care unit (ICU) stay. However, only
19% of surviving patients who were functionally dependent retrospectively agreed to neurocritical care.
Unfavorable functional outcome and the diagnosis of stroke were independent predictors for missing retrospective
consent.
Conclusions: Retrospective agreement to neurocritical care is influenced by functional outcome. Especially in
severely affected stroke patients who cannot communicate their preferences regarding life-sustaining therapy,
neurocritical care physicians should balance the expected burdens and benefits of treatment to meet the patients’
putative wishes. Efforts should be undertaken to identify predictors for severe disability after neurocritical care.
Introduction
In the past, physicians did not routinely seek permission
from patients before initiating diagnostic and therapeu-
tic procedures, regardless of the risk [1]. However, in
recent years, emphasis has been shifted from physician
sovereignty to patient autonomy, obliging physicians to
expect and encourage patient participation in decision
making after having given them all available relevant
information, thus obtaining the patient’si n f o r m e dc o n -
sent to perform the given procedure [2,3]. Neurologic
patients in need of intensive care, however, may not be
capable of participating in the informed-consent process,
because of reduced consciousness or severe aphasia.
Moreover, further clinical deterioration and complica-
tions may occur within the first hours after admission.
Rapid identification and implementation of a suitable
legal representative for participation in the consent pro-
cess can be difficult and, in some instances, not feasible.
Hence, in life-threatening situations, physicians perform
procedures without consent, assuming that most indivi-
duals would assent to be treated in this situation. This
approach has been widely discussed and agreed on
[1-3]. However, taking into account the possibility of an
unfavorable outcome after neurointensive care, would
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chance for survival with, conversely, the potential per-
spective of severe disability with the need for constant
nursing care or even delayed death?
Our objective was to assess patients’ retrospective will-
ingness to undergo neurocritical care, given that func-
tional outcome may be very poor. Furthermore, patients
and relatives, regardless of the functional outcome, were
asked whether they were satisfied with their treatment
on our neurocritical care unit.
Materials and methods
Patients and Setting
Between January 2006 and December 2007, 796 neuro-
logic patients were admitted to our 10-bed neurocritical
care unit (tertiary University Hospital). As we aimed to
investigate the retrospective consent to specialized neu-
rocritical care, we excluded 92 patients from this analy-
sis because of (a) being temporarily monitored only
after neuroradiologic procedures (n = 21), (b) represent-
ing outsourced patients from general ICUs (n =4 2 ) ,o r
(c) being lost to follow up (n = 29). A total of 704
patients remained eligible for the final analysis. The
institutional review board approved the study, and con-
sent was obtained in written or oral form from all
patients or their relatives/legal guardians.
Data collection
We obtained age, diagnoses, and medical history by
reviewing the patients’ hospital charts and institutional
electronic databases. Patients were grouped according to
their neurologic diagnoses (1, ischemic stroke; 2, intra-
cerebral hemorrhage (ICH); 3, subarachnoid hemorrhage
(SAH); 4, meningoencephalitis; 5, epileptic seizures; 6,
Guillain-Barré syndrome (GBS) and myasthenia gravis
(MG); 7, neurodegenerative diseases and encephalopa-
thy; 8, cerebral neoplasm; and 9, intoxication).
Patients or their relatives were contacted by using a
mailed standardized questionnaire, which was answered
by either the patient or the next of kin or the legal guar-
dian (the legal guardianship was reassessed in regular
intervals by the responsible courts). In all cases in which
this questionnaire did not return within 6 weeks, a
structured phone interview was conducted with the
patients or their closest relatives. The telephone inter-
views were performed by a stroke physician who was
trained and certified for data collection on disability,
quality of life, and the modified Rankin Scale (mRS).
Consent to participate in this study was obtained in
written or oral form from all patients or their relatives/
legal guardians. Because of functional impairment or
death, a proportion of patients were not able to answer
themselves (see Table 1).
End-point definition
Patients were asked to answerf o u rq u e s t i o n s :( a )f u n c -
tional status (expressed as mRS) before hospital admis-
sion, and (b) functional outcome (expressed as mRS)
12 months after hospital stay. Furthermore, patients
were asked (c) if they retrospectively agreed with the
treatment (that is, whether they would again consent to
neurocritical care, given the experienced functional out-
come 1 year after hospital stay). Consent was defined as
the retrospective approval of the applied life-saving
emergency procedures (for example, intubation, place-
ment of ventricular drains) on admission to the neuro-
critical care unit (thereby explaining that withdrawal of
consent would probably have correlated with rapid clini-
cal worsening and the probability of early death). The
possibility of answering the question of retrospective
consent to neurocritical care was dichotomized. Finally,
(d) patients were asked whether they were satisfied with
their hospital stay. Satisfaction was defined as general
contentment with the neuro-ICU (NICU) stay, wilfully
neglecting the functional outcome (that is, contentment
with how the patient and family members were covered
by the staff, educated with regard to the prognosis and
future course of the disease, and experienced decision
making). The questionnaire provided five possible
answers: very satisfied, satisfied, neither satisfied nor dis-
satisfied, dissatisfied, and very dissatisfied. The answers
‘very satisfied’ and ‘satisfied’ were categorized as satis-
fied, whereas ‘neither satisfied nor dissatisfied,’‘ dissatis-
fied,’ and ‘very dissatisfied’ were scored as dissatisfied.
Functional outcome was defined as favorable (mRS 0 to
1), mild to moderate disability (mRS 2 to 3), severe disabil-
ity (mRS 4 to 5), and dead (mRS 6) [4], and also as indepen-
dent (mRS 0 to 2) versus dependent or dead (mRS 3 to 6).
Statistical analysis
Statistical analyses were performed by using the SPSS
17.0 software package (SPSS Inc., Chicago, IL). Statistical
Table 1 Retrospective consent
mRS Patient replied (n/%) Relatives replied (n/%) P value
0 57 (100%) 0 <0.0001
1 98 (100%) 0 <0.0001
2 36 (100%) 0 <0.0001
3 44 (73.3%) 16 (26.7%) <0.0001
4 50 (79.4%) 13 (20.6%) <0.0001
5 9 (9.2%) 89 (90.8%) <0.0001
6 0 292 (100%) <0.0001
Total 294 (41.8%) 410 (58.2%)
Numbers of patients versus relatives who answered to the question of
retrospective consent for neurocritical care. Data are separately given,
depending on functional outcome of patients.
mRS, modified Rankin Scale; n, number.
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a = 0.01. The distribution of the data was assessed with
the Kolmogorov-Smirnov test. Continuous and categoric
variables are expressed as median and range, or as per-
centage, as appropriate. Proportions between two groups
were compared by using the c
2 test, Fisher’sE x a c tt e s t ,
or the Mann-Whitney U test, as appropriate.
One stepwise forward-inclusion multivariate logistic
regression model was calculated to determine para-
meters that independently predisposed for retrospective
consent. Those parameters that showed at least a trend
in univariate testing (P < 0.1) were included into the
multivariate analysis. The parameter mRS was entered
as a nominal variable. Interaction terms did not reveal
significant interaction between the variables.
Results
The demographic and clinical characteristics of the ana-
lyzed 704 patients, as well as overall amount of consent
and satisfaction, are given in Table 2. Of 241 patients
with cerebral ischemia, 14 received decompressive sur-
gery for malignant middle cerebral artery infarction, 11
of whom retrospectively consented to neurointensive
care. Of 205 patients with ICH, hematoma evacuation
was performed in 27 patients, nine of whom retrospec-
tively consented.
Overall satisfaction was high (>90%) and did not
depend on age, functional status before admission, sex,
or the necessity of mechanical ventilation. Analysis of
satisfaction according to diagnoses, however, revealed
that patients with epilepsy were less satisfied than the
general cohort (P < 0.01). The declared satisfaction
depending on the possible answers is shown in Figure 1.
In contrast, retrospective consent was given in 51% of
all patients only and was lowest in patients with stroke
(P < 0.001; Table 2). The specific analysis of retrospec-
tive consent according to functional outcome is shown
in Figure 2. Patients without disability (mRS 0 to 1), or
who were only mildly to moderately disabled (mRS 2 to
3), consented to neurocritical care in 94%, and 76%,
respectively, whereas patients with a mRS of 4 to 5 con-
sented in only 19%. Relatives of patients who had died 1
year after disease onset gave retrospective consent in
38% (comparison between all groups: P < 0.001).
An outcome-based analysis of retrospective consent
according to the specific diagnoses is given in Table 3.
The logistic regression analysis of parameters that
Table 2 Demographic and clinical data
All Ischemia ICH SAH Meningoencephalitis Epilepsy GBS/
MG
Neurodeg./
Enceph.
Cerebral
neoplasm
Intox.
n (%) 704 241
(34.2)
205
(29.1)
37 (5.3) 47 (67) 86 (12.2) 24 (3.4) 20 (2.8) 19 (2.7) 25 (3.6)
Age (median, range) 67 (18-
95)
72 (21-
93)
70 (35-
95)
56 (19-
84)
63 (27-85) 59 (18-
93)
58 (23-
78)
66 (23-85) 65 (39-78) 53 (29-
78)
Female sex (n, %) 328
(46.6)
107
(44.4)
95
(46.3)
19
(51.4)
24 (51.1) 42 (48.8) 13
(54.2)
13 (65.0) 7 (36.8) 8 (32.0)
Mechanical ventilation
(n,% )
447
(63.5)
143
(59.3)
141
(68.8)
20
(54.1)
40 (85.1) 44 (51.2) 15
(62.5)
17 (85.0) 7 (36.8) 20
(80.0)
Preadmission
mRS 0-2 (n,% )
628
(89.2)
226
(93.7)
180
(87.8)
34
(91.9)
42 (89.4) 63 (73.3) 23
(95.8)
9 (45.0) 6 (31.6) 45
(96.0)
Consent of all patients
(n,% )
361
(51.3)
98 (40.7) 76
(37.1)
23
(62.1)
38 (80.9) 62 (72.1) 19
(79.2)
11 (55.0) 14 (73.7) 20
(80.0)
Satisfaction (n, %) 643
(91.3)
224
(92.9)
195
(95.1)
35
(94.6)
45 (95.7) 65 (75.6) 22
(91.7)
18 (90.0) 16 (84.2) 23
(92.0)
Demographic and clinical characteristics as well as overall consent and satisfaction of all patients (n = 704) separated for diagnoses.
ICH, Intracranial hemorrhage; SAH, subarachnoid hemorrhage; GBS, Guillain-Barré syndrome; MG, myasthenia gravis; Neurodeg, neurodegenerative disease;
Enceph, encephalopathy; Intox, intoxication; n, number; mRS, modified Rankin Scale.
Figure 1 Declared satisfaction, depending on the possible
answers (very satisfied, satisfied, neither satisfied nor
dissatisfied, dissatisfied, very dissatisfied).
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Independent predictors for retrospective withdrawal of
consent to neurocritical care were (a) worse functional
outcome (expressed as an increase in the mRS), and (b)
the diagnoses of ischemic and hemorrhagic stroke.
Discussion
In this study, we investigated the frequency of retrospec-
tive agreement to the applied neurocritical care in corre-
lation to neurologic disease and functional outcome. As
a key finding, consent was high in patients with good
functional outcome, whereas survival with a poor func-
tional condition was related to the lowest rates of con-
sent, especially in stroke patients.
First, it must noted that patients with acute onset of
severe neurologic disease frequently are not capable of
expressing their preferences regarding acceptance or
decline of life-sustaining procedures [5,6]. Moreover, in
the acute situation, a potentially existing advance direc-
tive may not be at hand [7], and relatives, if present, may
be too distraught to participate appropriately in the deci-
sion process [8]. In addition, a dissociation of patients’
and relatives’ perception appears to exist in that regard,
that survival itself does not necessarily imply survival
with excellent outcome [9]. This may be caused partly by
shortcomings during the informed-consent process for
planned procedures [9].
Consent to neurointensive care measures the indivi-
dual’s satisfaction with being alive. Other studies of non-
neurologic patients have s h o w nt h a ta na g e - r e l a t e d
correlation might exist between older age and an incline
in life satisfaction in women; however, this has not been
Figure 2 Consent and satisfaction depending on functional outcome 1 year after discharge. Although no differences in overall satisfaction
were noted among the outcome groups, the c
2 Test for retrospective consent revealed significant differences between the four groups (P < 0.001).
Table 3 Consent to treatment
Ischemia ICH SAH Meningoencephalitis Epilepsy GBS/MG Neurodeg./
Enceph.
Cerebral
neoplasm
Intox.
mRS 0-1 (n, %) 24/25 (96.0) 28/30 (93.3) 9/9 (100.0) 23/24 (95.87) 44/49 (89.8) 10/10 (100.0) 1/1 (100.0) 0/0 7/7 (100.0)
mRS 2-3 (n, %) 35/44 (79.9) 13/17 (76.5) 1/2 (50.0) 5/7 (71.4) 1/4 (25.0) 7/9 (77.8) 2/3 (66.7) 2/2 (100.0) 7/8 (87.5)
mRS 4-5 (n, %) 4/68 (5.8) 3/41 (7.3) 4/8 (50.0) 5/9 (55.6) 8/19 (42.1) 1/4 (25.0) 2/6 (33.3) 1/2 (50.0) 2/4 (50.0)
mRS 6
(n,% )
35/104 (33.7) 32/117 (27.4) 9/18 (50.0) 5/7 (71.4) 9/14 (64.3) 1/1 (100.0) 6/10 (60.0) 11/15 (73.3) 4/6 (66.7)
Consent to treatment (%) according to diagnosis and separated by functional outcome, that is, the proportion of patients with a specific disease and with a
specific outcome who retrospectively agreed and consented to neurocritical care.
ICH, Intracranial hemorrhage; SAH, subarachnoid hemorrhage; GBS, Guillain-Barré syndrome; MG, myasthenia gravis; neurodeg, neurodegenerative disease;
Enceph, encephalopathy; Intox, intoxication; n, number; mRS, modified Rankin Scale.
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was found between consent and age or sex. Further-
more, several studies showed a relation between chronic
neurologic illnesses and less life satisfaction [12-15]. As
experienced, severe neurologic diseases, which led to
neurointensive care, may have a long-term outcome
similar to that of severe chronic diseases; this is in line
with our results that more-severe long-term conse-
quences lead to less retrospective consent.
The literature on the correlation of retrospective
agreement to specific invasive treatment and functional
outcome is less conclusive. Although Foerch and collea-
gues [16] reported a correlation between the retrospec-
tive decision against treatment and rather unfavorable
outcome, and Walz and co-workers [17] also concluded
that consent might depend on outcome in patients
undergoing hemicraniectomy, other authors did not find
a relation between functional outcome and retrospective
agreement to therapy [18-20]. In another study, the will-
ingness of patients to undergo intensive care to achieve
even 1 additional month of survival was high; however,
when asked if this would also apply if the patients were
in a vegetative or severely neurologically impaired state,
willingness to undergo intensive care was much less
[21]. This again shows that there may be a difference in
accepting general intensive care compared with neuro-
intensive care, as the latter is associated with a higher
likelihood of cognitive impairment.
Several novel issues presented here add to this discus-
sion. Consent to neurocritical care declines with increas-
ing disability. However, in patients who died in the
course of the disease, increased rates of consent were
presumed by the families. This reflects a previously
unnoticed and highly important finding. These results
indicate that death may not be judged to be the worst
o u t c o m eb ys o m ep a t i e n t so rt h e i rr e l a t i v e s ,a n dap r o -
portion of patients may prefer death to severely disabled
survival or a vegetative state [7,22-26].
The data presented here have several shortcomings.
Data were collected in a single center, and the sample
size may have limited the statistical power. Furthermore,
because of intercultural differences, the results may not
be internationally valid. In addition, consent was
assessed one year after neurocritical care; however,
answers given in questionnaires or telephone interviews
have an inherent dependence on how the questions are
stated, thus possibly leading to discrepancies across
similar studies. Furthermore, other possibly important
parameters, such as depression, were not collected.
Finally, the fact that exclusively relatives have answered
the questionnaires in all cases in which patients had
died, represents a systemic bias, as the provision of
time, money, and manpower when caring for patients at
home versus transferring them into a nursing home may
affect the given answers.
Conclusions
Two aspects – (a) incapability to state preferences
regarding life-sustaining therapies after symptom onset
and missing advance directive, and (b) absent consent to
neurocritical care if survival is poor – lead to a thera-
peutic dilemma in neurocritical care. Precisely because
the majority of patients are not capable of stating their
treatment preferences, a general initiation of neurocriti-
cal care assumes the patients’ agreements in the acute
phase [27-30]. This may result in prolonged disease
duration and partly delays the decision to limit treat-
ment until severe complications occur during the course
of the disease [22,31,32]. The finding that patients con-
sent to neurocritical carem a i n l yi ft h ef u n c t i o n a l
Table 4 Parameters predicting retrospective consent
Consent to treatment
OR (95% CI)
P value
Univariate analysis
Demographic data
Age 2.800 (0.350-5.808) 0.1057
Sex: female 3.407 (0.438-8.071) 0.1853
Mechanical ventilation 3.082 (0.414-22.923) 0.2716
Funct. status preadmission 1.263 (0.380-4.203) 0.7033
Diagnosis
Ischemia 0.440 (0.316-0.612) <0.0001
ICH 0.441 (0.312-0.625) <0.0001
SAH 1.408 (0.689-2.880) 0.3482
Meningoencephalitis 4.019 (1.908-8.470) 0.0003
Epilepsy 2.627 (1.581-4.363) 0.0002
GBS/MG 3.560 (1.313-9.650) 0.0126
Neurodeg./Encephalopathy 0.872 (0.764-1.031) 0.0219
Cerebral neoplasm 0.623 (0.453-0.824) 0.0038
Intoxication 1.259 (0.853-1.738) 0.6432
Functional status at 1 year
after discharge
mRS 0.588 (0.538-0.642) <0.0001
Multivariate analysis
Ischemia 0.294 (0.169-0.509) <0.0001
ICH 0.306 (0.173-0.541) <0.0001
Meningoencephalitis 1.076 (0.426-2.721) 0.8764
Epilepsy 0.568 (0.274-1.179) 0.1289
GBS/MG 0.698 (0.218-2.230) 0.5426
Neurodeg./Encephalopathy 0.821 (0.691-1.368) 0.2574
Cerebral neoplasm 0.572 (0.378-0.911) 0.0097
mRS 0.610 (0.555-0.671) <0.0001
Univariate and multivariate regression analysis to identify predisposing
parameters for retrospective consent to neurocritical care. Parameters that
reached significance (P < 0.01) are expressed in bold.
OR, odds ratio; CI, confidence interval; Funct, functional; ICH, intracranial
hemorrhage; SAH; subarachnoid hemorrhage; GBS, Guillain-Barré syndrome;
MG, myasthenia gravis; Neurodeg, neurodegenerative disease; mRS, modified
Rankin Scale.
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the following two issues that need further societal, ethi-
cal, and legal clarification: (a) efforts should be underta-
ken to achieve a greater public awareness of the
necessity of advance directives, and (b) future investiga-
tions ultimately must focus on the identification of
highly sensitive and specific predictors for outcome
according to neurologic disease. Nonetheless, it will, in
all likelihood, remain an ethical discussion whether to
initiate neurocritical care in patients in whom palliative
therapy may to be more appropriate.
Key messages
￿ Retrospective consent in neurointensive care was
in patients with good functional outcome, whereas
survival with a poor functional condition was related
to the lowest rates of consent, especially in stroke
patients.
￿ Missing advance directives and assumed patients’
agreements in the acute situation may lead to a gen-
eral initiation of neurocritical care, which leads to
prolonged disease duration.
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